Skip to content

Drug interactions

Lumacaftor / ivacaftor + Nateglinide

Severity: Moderate

Lumacaftor / ivacaftor and Nateglinide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lumacaftor is an inducer and ivacaftor a weak inhibitor of CYP2C9, so the net effect on nateglinide exposure is unpredictable. Glycemic control could be lost if nateglinide levels fall, or hypoglycemia could occur if they rise.

What this interaction means in plain words

Lumacaftor / ivacaftor and Nateglinide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Opposing effects on CYP2C9: induction by lumacaftor and inhibition by ivacaftor alter nateglinide metabolism.

What to do

Monitor blood glucose closely when starting or stopping lumacaftor/ivacaftor and adjust the nateglinide dose according to glycemic response.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lumacaftor / ivacaftor and Nateglinide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lumacaftor / ivacaftor with Nateglinide?

MediHelp rates the interaction as moderate. Lumacaftor / ivacaftor and Nateglinide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lumacaftor is an inducer and ivacaftor a weak inhibitor of CYP2C9, so the net effect on nateglinide exposure is unpredictable. Glycemic control could be lost if nateglinide levels fall, or hypoglycemia could occur if they rise.

How serious is the interaction between Lumacaftor / ivacaftor and Nateglinide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose closely when starting or stopping lumacaftor/ivacaftor and adjust the nateglinide dose according to glycemic response.

What other medicines interact with Nateglinide?

MediHelp also lists interactions of Nateglinide with, for example, Albiglutide, Alogliptin-metformin, Alogliptin-pioglitazone. The full list is on the Nateglinide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in